Answer
Yes, immediate and delayed infusion-related reactions, as well as anaphylactic reactions, have been reported with brentuximab vedotin (Adcetris).
Sources for this answer
- Adcetris 50 mg powder for concentrate for solution for infusionTakeda UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 33Document updated
Sources checked